Article Versions Notes

Reina-Ortiz C, Giraldos D, Azaceta G, Palomera L, Marzo I, Naval J, Villalba M, Anel A. Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma. Cells. 2022; 11(3):392. https://doi.org/10.3390/cells11030392

Reina-Ortiz, Chantal, David Giraldos, Gemma Azaceta, Luis Palomera, Isabel Marzo, Javier Naval, Martín Villalba, and Alberto Anel. 2022. "Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma" Cells 11, no. 3: 392. https://doi.org/10.3390/cells11030392

Reina-Ortiz, C., Giraldos, D., Azaceta, G., Palomera, L., Marzo, I., Naval, J., Villalba, M., & Anel, A. (2022). Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma. Cells, 11(3), 392. https://doi.org/10.3390/cells11030392